Loading startup
Market data is refreshed once per day from public sources. Information may be incomplete or outdated — verify independently before making decisions. This is not investment advice.
Evidence-bound summary — expand sections for movement, risks, and signals.
Memo snapshot · May 20, 2026, 6:22 PM
What would change this read
DealFlow OS uses public web data and automated enrichment. Research may be incomplete, outdated, or incorrect. Verify important information before making investment or outreach decisions.
TL;DR
Seed (YC)ClaimGlide Automate prior-auth submissions and appeals with AI.
Raised $500K across 1 funding round. Latest: $500K Pre-seed (Jan 2026). Investors: Y Combinator. (High).
Funding
Raised $500K across 1 funding round. Latest: $500K Pre-seed (Jan 2026). Investors: Y Combinator. (High).
Product / news
1 product/news‑styled row(s); headline risk without filings (High).
Verified facts
YC Winter 2026; end-to-end prior authorization automation for private medical practices.
Weak funding evidence: mention does not include a parsed raise amount/round and may refer to non-funding context.
No open roles indexed yet.
The index price and activity score are algorithmic estimates based on observed public company-level signals. They may be incomplete, stale, or inaccurate and are not investment, legal, tax, or business advice.
Source types found
Strongest / recent news-style rows
Wed, May 20, 06:22 PM · confidence 88%high quality
Newest first · 4 event(s)
Source: official_site
--> ClaimGlide | Automate Prior-Auths Submissions & Appeals contact@claimglide.com Book Demo Contact Us Book Demo Backed by top investors Custom AI prior-auth automation software. Increase your revenue by getting more prior-auths approved, faster, without ext…
Automate prior-auth submissions and appeals with AI.
YC Winter 2026; end-to-end prior authorization automation for private medical practices.
Prior-auth automation for specialty practices.
3 row(s)
The company's own site — the authoritative description of what they sell and to whom. Marketing-controlled, so treat claims as positioning rather than verified traction.
--> ClaimGlide | Automate Prior-Auths Submissions & Appeals contact@claimglide.com Book Demo Contact Us Book Demo Backed by top investors Custom AI prior-auth automation software. Increase your revenue by getting more prior-auths approved, faster, without ext…
Why it matters: Primary source — the company's own positioning; best read for what they sell and to whom, not for traction claims.
Open source ↗Automate prior-auth submissions and appeals with AI.
Why it matters: Primary source — the company's own positioning; best read for what they sell and to whom, not for traction claims.
Open source ↗Prior-auth automation for specialty practices.
Why it matters: Primary source — the company's own positioning; best read for what they sell and to whom, not for traction claims.
Open source ↗1 row(s)
Funding announcements and investor-database records. The strongest public signal of capitalization: round, amount, and syndicate quality when disclosed.
YC Winter 2026; end-to-end prior authorization automation for private medical practices.
Why it matters: Funding signal — Pre-Seed per this source; verify against the linked original before relying on it.
Open source ↗Sign in as an active team member to view private notes, watchlist controls, transcript evidence, and interaction history.